Generic versions of CSL’s iron replacement therapy Venofer have arrived in the U.S. after a yearslong wait. | Generic ...

World Agricultural Supply and Demand Estimates (WASDE) report raised its forecast of US sugar production for this year and for 2025-26, made only minor changes in imports and use, and boosted the 2024 ...

Breaks down the chemical properties of cotton versus sucrose, exploring why appearance can be deceiving in edible and ...

The most common test used by sugar companies, such as American Crystal Sugar, is ICUMSA-420. Producers assign a color value ...

From a raw material perspective, Sugar Cane is poised to maintain its dominance, holding an estimated 54.7% market share in ...

On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated ...

Amphastar Pharmaceuticals (AMPH) upgraded to Buy by Needham after FDA approval for generic iron sucrose injection, marking ...

Building on their success developing a cleaner way to make valuable organic acids, researchers from the Center for Advanced ...

Understanding bees’ capabilities is, for Muth, a part of a fully-lived experience. “One of the joys of being human is being ...

Iron sucrose injection is an iron replacement product indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease.

Venofer was approved in the U.S. in 2000. It was developed by Vifor Pharma, which is now part of CSL Ltd. American Regent, a unit of Daiichi Sankyo, manufactures and sells it in the U.S. under a ...

Viatris (VTRS) stock gains as the FDA OK its generic Iron Sucrose Injection targeting Venofer marketed by Daiichi Sankyo (DSKYF) (DSNKY) and Vifor. Read more here.